<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719009</article-id><article-id pub-id-type="pmc">6852445</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Preoperative Carotid Duplex Scanning in Patients Undergoing Coronary
Artery Bypass Grafting</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5850-5920</contrib-id><name><surname>Kara</surname><given-names>Hakan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, Giresun Ada Hospital,
Giresun, Turkey.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: <bold>Hakan Kara</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-5850-5920">https://orcid.org/0000-0002-5850-5920</ext-link>, Department of
Cardiovascular Surgery, Giresun Ada Hospital, Giresun, Zip code: 28100. E-mail:
<email>hakankarakdc@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>581</fpage><lpage>587</lpage><history><date date-type="received"><day>30</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>7</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>The aim of this study was to determine the prevalence and risk factors of
carotid artery stenosis (CAS) using carotid duplex ultrasound in patients
undergoing coronary artery bypass grafting (CABG).</p></sec><sec><title>Methods</title><p>This retrospective study was conducted between January 2017 and January 2018
and included 166 consecutive patients [130 males (78.31%), 36 females
(21.69%); mean age: 64.25&#x000b1;9.78 years] who underwent elective and
isolated CABG. Patients who had significant CAS (&#x02265;50% stenosis) were
compared with patients who had non-significant CAS (&#x0003c;50% stenosis).
Logistic regression analysis was applied across the selected parameters to
identify risk factors for significant CAS.</p></sec><sec><title>Results</title><p>Of all patients, 36 (21.68%) had CAS &#x02265;50% and 8 (4.81%) had unilateral
carotid stenosis &#x02265;70%. Carotid endarterectomy/CABG was performed
simultaneously in five (3.01%) patients. None of these patients had cardiac
and neurological problems during the postoperative period. The overall
incidence of cerebrovascular accident (CVA) after CABG was 1.20% (n=2). Age
(<italic>P</italic>=0.011) and history of CVA (<italic>P</italic>=0.035)
were significantly higher in the CAS &#x02265;50 group than in the CAS &#x0003c;50
group. Significant CAS was identified as a risk factor for postoperative CVA
(<italic>P</italic>=0.013).</p></sec><sec><title>Conclusion</title><p>Age and history of CVA were identified as risk factors for significant CAS.
Furthermore, significant CAS was identified as a risk factor for
postoperative CVA. For this reason, carotid screening is recommended for
patients undergoing CABG even in the absence of associated risk factors.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Carotid Endarterectomy</kwd><kwd>Carotid Stenosis</kwd><kwd>Risk</kwd><kwd>Factors</kwd><kwd>Stroke</kwd><kwd>Ultrasonography, Doppler, Duplex</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="4%" span="1"/><col width="44%" span="1"/><col width="4%" span="1"/><col width="4%" span="1"/><col width="44%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th><th align="center" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACAS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Asymptomatic Carotid
Artery Study</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">EACTS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Association for
Cardio-Thoracic Surgery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Activated clotting
time</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ESC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Society of
Cardiology</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrial fibrillation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECST</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= European Carotid Surgery
Trial</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ASA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acetylsalicylic
acid</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">HT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Hypertension</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Internal carotid
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CAS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Carotid artery
stenosis</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LMCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left main coronary
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Common carotid
artery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NASCET</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= North American
Symptomatic Carotid Endarterec tomy Trial</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CEA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Carotid
endarterectomy</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Odds ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Peripheral arterial
disease</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SVG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Saphenous vein
graft</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cerebrovascular
accident</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TIA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transient ischemic
attack</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DM</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DUS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Duplex ultrasound</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>The coexistence of carotid and coronary artery diseases is an important pathology for
cardiovascular surgeons. Carotid artery stenosis (CAS) is a significant risk factor
for cerebrovascular accident (CVA) in cardiac surgery<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Preoperative screening and management of CAS in
patients undergoing coronary artery bypass grafting (CABG) is important to reduce
morbidity. It is unclear whether preoperative carotid screening should be applied to
all patients<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Carotid duplex
ultrasound (DUS) is the cheapest and most available method to accurately identify
significant extracranial carotid stenosis<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Some centers perform preoperative carotid DUS on selected
patients, while others perform it routinely<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. North American Symptomatic Carotid Endarterectomy Trial
(NASCET), European Carotid Surgery Trial (ECST), and the Asymptomatic Carotid Artery
Study (ACAS) have reported that carotid endarterectomy (CEA) reduces the risk of CVA
in symptomatic or asymptomatic patients with severe CAS<sup>[<xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r7" ref-type="bibr">7</xref>]</sup>. In a
meta-analysis, cardiac surgery patients with symptomatic/asymptomatic 50-99%
stenosis or occlusion had a 7.4% CVA risk, which further increased to 9.1% in those
with 80-99% stenosis or occlusion<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Based on these data, it can be said that among patients
scheduled for CABG, it is highly important to identify patients with severe CAS in
the preoperative period and treat them with CEA, and to take patients with moderate
CAS into follow-up programs. The aim of this study was to determine the prevalence
and risk factors of CAS using carotid DUS in patients undergoing CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This retrospective study was performed on patients who underwent preoperative carotid
DUS prior to scheduled elective primary isolated CABG between January 2017 and
January 2018. The study included 166 consecutive patients [130 males (78.31%), 36
females (21.69%)], with a mean age of 64.25&#x000b1;9.78 years. Exclusion criteria
included preoperative atrial fibrillation (AF), postoperative AF, antiarrhythmic
treatment (other than beta-blockers), off-pump CABG, preoperative chronic
obstructive pulmonary disease, emergency surgeries, redo surgery, bleeding and/or
tamponade revision, chronic kidney failure, and combined (other than CEA) surgeries.
The study was approved by the Ethics Review Committee of Karadeniz Technical
University Faculty of Medicine (number: 31.12.2018/ 295). All protocols were in
compliance with the ethical guidelines of the Declaration of Helsinki of 1975.</p><p>Data collected included patient demographics, comorbidities, history of previous CVA,
preoperative carotid artery duplex scan results, postoperative CVA, and
postoperative details. Evaluation of internal carotid artery (ICA) stenosis was
performed with DUS. The carotid DUS of all patients were performed by the same
radiologist. Ultrasonic examination of the neck was performed using a commercial
Doppler device (GE Logic S6, USA) with a linear probe 8.0-12.0 MHz to determine the
presence of an atheroma or occlusion blood flow involving the carotid arteries
bilaterally. Color Doppler was used to obtain blood flow velocities in the common
(CCA), internal (ICA), and external carotid arteries. Parameters recorded were ICA
peak systolic velocity, ICA/common carotid artery peak systolic velocity ratio and
ICA end-diastolic velocity. The presence of plaque, calcification, and intimal
thickening involving the carotid vessels was observed. A diagnosis of CAS made its
severity graded according to the Society of Radiologists in Ultrasound
criteria<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. The standard
protocol applied to all patients was based on the following criteria for defining a
significant carotid stenosis: ICA peak systolic velocity of &#x02265;250 cm/s, ICA
end-diastolic velocity &#x02265;120 cm/s, and velocity to the ICA (VICA)/velocity to
the CCA (VCCA) of &#x0003e;1.8 to the systolic phase and &#x0003e;2.6 to the diastolic phase.
Patients were classified into five groups as shown in <xref ref-type="fig" rid="f1">Figure 1</xref>. A bruit may not be heard as the grade of stenosis in the
carotid arteries increases. The presence or absence of a cervical bruit is a poor
indicator of a high-grade carotid stenosis, even in the setting of known symptomatic
disease (sensitivity 63%, specificity 61%)<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. For this reason, bruit was not evaluated in our study
during the preoperative evaluation. Patients with significant CAS (&#x02265;50%
stenosis) and those with &#x0003c;50% stenosis were compared in terms of age, gender,
diabetes mellitus (DM), hypertension (HT), dyslipidemia, body mass index (BMI),
peripheral arterial disease (PAD), smoking, history of cerebrovascular accident
(CVA), number of graft vessels, and left main coronary artery (LMCA) disease.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Outcome summary for the 166 CABG patients who underwent preoperative
screening. CABG=coronary artery bypass grafting; CEA=carotid
endarterectomy; DUS=Doppler ultrasound; pts=patients</p></caption><graphic xlink:href="rbccv-34-05-0581-g01"/></fig>
</p><p>A routine preoperative evaluation was performed for each patient. In our study, other
antiagregant and anticoagulant drugs excluded acetylsalicylic acid (ASA) were
withdrawn before CABG. Patients with critical coronary artery disease or significant
carotid artery stenosis (&#x02265;50% stenosis) were treated with ASA and
low-molecular-weight heparin. Premedication, induction, and maintenance anesthesia,
along with intraoperative hemodynamic monitoring and anticoagulation, were performed
according to the standard protocol. Surgery was performed using median sternotomy.
The left internal thoracic artery (LITA) and the saphenous vein graft (SVG) were
prepared. Standard cardiopulmonary bypass (CPB) techniques (St&#x000f6;ckert S3 Sorin
Group, Italy) with moderate systemic hypothermia (28-30&#x000b0;C) were employed. Myocardial
preservation was achieved by antegrade blood cardioplegia for cardiac arrest and
maintenance with antegrade and retrograde blood cardioplegia. Proximal anastomoses
were performed with a single clamp. Prior to initiation of CPB, all patients
received a standard heparin dosage of 300 IU/kg bodyweight, with an additional
optional bolus of 50 IU/kg prior to cannulation. Anticoagulation was monitored by
serial measurements of activated clotting time (ACT), which was kept &#x0003e; 450 s at
all times during CPB. Heparin was reversed by administering 1 mL of protamine for
each 1000 IU heparin, and ACT return to baseline served as confirmation. Carotid
artery angiography was also performed in patients with severe stenosis identified by
carotid DUS and planned for CEA. Angiographic and carotid DUS data were consistent
with each other. CEA was performed under general anesthesia simultaneously with
CABG. CEA was performed first. During CEA, the use of shunt was decided by assessing
the retrograde flow in ICA. Shunt was used in one patient who was thought to have
inadequate retrograde flow and whose stump pressure was measured as 25 mmHg and was
not required in the other four patients. Because the ICA diameter was &#x0003e;4 mm,
arteriotomy was primarily closed in all patients.</p><sec><title>Evaluation of Carotid Artery Stenosis</title><p>All patients scheduled for elective CABG surgery underwent routine preoperative
duplex ultrasonography scanning of the carotid artery to assess for stenosis.
The degree of stenosis was grouped into five categories: no stenosis, 20 to 49%
(mild stenosis), 50 to 69% (moderate stenosis), &#x02265;70% (severe stenosis),
and total occlusion based on peak systolic and diastolic velocities (<xref ref-type="fig" rid="f1">Figure 1</xref>). Our institution&#x02019;s criteria for CEA
prior to or concurrent with cardiac surgery is symptomatic patients with &#x0003e;50%
stenosis or asymptomatic patients with &#x0003e;70% bilateral stenosis and
asymptomatic patients with &#x0003e;80% unilateral stenosis.</p></sec><sec><title>Postoperative Cerebrovascular Accident</title><p>A postoperative CVA or stroke was defined as a persistent focal or multifocal
neurological deficit, explained as a brain or brainstem ischemia that occurs
from the time of surgery until the 30<sup>th</sup> postoperative day, and
confirmed using magnetic resonance imaging. Neurocognitive dysfunction was not
assessed in our study.</p></sec><sec><title>Statistical Analysis</title><p>Clinical characteristics are presented as mean &#x000b1; standard deviation for
continuous variables and proportions for categorical variables. Data are
presented as frequencies and percentages according to the type. Statistical
analyses were conducted using Statistical Package for the Social Sciences
(version 23.0; IBM Corporation, Armonk, NY, USA) software, and
<italic>P</italic>&#x0003c;0.05 was considered statistically significant.
Logistic regression analysis was used to obtain odds ratio (OR) and the
corresponding 95% confidence interval (CI) to analyze risk factors.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 166 patients (130 males, 78.31%; 36 females, 21.69%; median age
64.25&#x000b1;9.78 years) underwent carotid artery DUS before undergoing CABG within
the study period. Among the patients, 56 (33.73%) had 20-49% CAS, and 28 (16.86%)
had 50-69% CAS. Of these, four (2.40%) had bilateral 50-69% CAS. Further, six
(3.61%) patients had &#x02265; 70-99% CAS. In two (1.20%) patients, total occlusion
was detected in any of the carotid arteries (<xref ref-type="fig" rid="f1">Figure
1</xref>). Two (1.20%) patients underwent intervention in one of the carotid
arteries before CABG. Furthermore, 34 (20.48%) patients had LMCA disease. Of the six
patients with 70-99% CAS, five (3.01%) underwent simultaneous combined CEA/CABG, and
four of these patients had unilateral 90% CAS and the remaining one had symptomatic
70% CAS. One patient with unilateral asymptomatic 70% stenosis underwent CABG only.
The mean age of eight patients with &#x02265;70% stenosis was 66.00&#x000b1;11.94
(range 54-82) years.</p><p>Demographic characteristics of patients with CAS &#x02265;50% and CAS &#x0003c;50% were:
age (68.66&#x000b1;9.46 <italic>vs</italic>. 63.04&#x000b1;9.55), male gender (n=29,
80.55% <italic>vs</italic>. n=101, 77.69%), DM (n=16, 44.44% <italic>vs</italic>.
n=49, 37.69%), HT (n=30, 83.33% <italic>vs</italic>. n=96, 73.84%), dyslipidemia
(n=19, 52.77% <italic>vs</italic>. n=68, 52.30%), BMI (26.83&#x000b1;2.92
<italic>vs</italic>. 26.90&#x000b1;3.38), history of PAD (n=6, 16.66%
<italic>vs</italic>. n=11, 8.46%), smoking (n=27, 75.00% <italic>vs</italic>.
n=96, 73.84%), history of CVA (n=5, 13.88% <italic>vs</italic>. n=2, 1.53%), EF
(61.22&#x000b1;8.84 <italic>vs</italic>. 61.75&#x000b1;9.91), aortic cross-clamp time
(75.50&#x000b1;18.46 <italic>vs</italic>. 76.11&#x000b1;23.66), total perfusion time
(116.31&#x000b1;20.56 <italic>vs</italic>. 117.34&#x000b1;28.72), number of graft
vessels (3.86&#x000b1;0.99 <italic>vs</italic>. 3.41&#x000b1;0.92), and LMCA disease
(n=10, 27.77% <italic>vs</italic>. n=24, 18.46%) (<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="3" colspan="1">Variables</th><th align="center" colspan="2" rowspan="1">CAS (&#x02265;50%)</th><th align="center" colspan="2" rowspan="1">No CAS (&#x0003c;50%)</th><th align="center" colspan="2" rowspan="1">All patients</th></tr><tr><th align="center" colspan="2" rowspan="1">n=36</th><th align="center" colspan="2" rowspan="1">n=130</th><th align="center" colspan="2" rowspan="1">n=166</th></tr><tr><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Mean age (years&#x000b1;SD) (min-max)</td><td align="center" colspan="2" rowspan="1">68.66&#x000b1;9.46</td><td align="center" colspan="2" rowspan="1">63.04&#x000b1;9.55</td><td align="center" colspan="2" rowspan="1">64.25&#x000b1;9.78</td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender</td><td align="center" colspan="2" rowspan="1">29 (80.55)</td><td align="center" colspan="2" rowspan="1">101 (77.69)</td><td align="center" colspan="2" rowspan="1">130 (78.31)</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" colspan="2" rowspan="1">16 (44.44)</td><td align="center" colspan="2" rowspan="1">49 (37.69)</td><td align="center" colspan="2" rowspan="1">65 (39.15)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" colspan="2" rowspan="1">30 (83.33)</td><td align="center" colspan="2" rowspan="1">96 (73.84)</td><td align="center" colspan="2" rowspan="1">126 (75.90)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" colspan="2" rowspan="1">19 (52.77)</td><td align="center" colspan="2" rowspan="1">68 (52.30)</td><td align="center" colspan="2" rowspan="1">87 (52.41)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (mean&#x000b1;SD)</td><td align="center" colspan="2" rowspan="1">26.83&#x000b1;2.92</td><td align="center" colspan="2" rowspan="1">26.90&#x000b1;3.38</td><td align="center" colspan="2" rowspan="1">26.88&#x000b1;3.27</td></tr><tr><td align="left" rowspan="1" colspan="1">History of PAD</td><td align="center" colspan="2" rowspan="1">6 (16.66)</td><td align="center" colspan="2" rowspan="1">11 (8.46)</td><td align="center" colspan="2" rowspan="1">17 (10.24)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" colspan="2" rowspan="1">27 (75.00)</td><td align="center" colspan="2" rowspan="1">96 (73.84)</td><td align="center" colspan="2" rowspan="1">123 (74.09)</td></tr><tr><td align="left" rowspan="1" colspan="1">History of CVA</td><td align="center" colspan="2" rowspan="1">5 (13.88)</td><td align="center" colspan="2" rowspan="1">2 (1.53)</td><td align="center" colspan="2" rowspan="1">7 (4.22)</td></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricular ejection fraction</td><td align="center" colspan="2" rowspan="1">61.22&#x000b1;8.84</td><td align="center" colspan="2" rowspan="1">61.75&#x000b1;9.91</td><td align="center" colspan="2" rowspan="1">61.63&#x000b1;9.66</td></tr><tr><td align="left" rowspan="1" colspan="1">ACCT (min)</td><td align="center" colspan="2" rowspan="1">75.50&#x000b1;18.46</td><td align="center" colspan="2" rowspan="1">76.11&#x000b1;23.66</td><td align="center" colspan="2" rowspan="1">75.98&#x000b1;22.58</td></tr><tr><td align="left" rowspan="1" colspan="1">TPT (min)</td><td align="center" colspan="2" rowspan="1">116.31&#x000b1;20.56</td><td align="center" colspan="2" rowspan="1">117.34&#x000b1;28.72</td><td align="center" colspan="2" rowspan="1">117.12&#x000b1;27.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of graft vessels</td><td align="center" colspan="2" rowspan="1">3.86&#x000b1;0.99</td><td align="center" colspan="2" rowspan="1">3.41&#x000b1;0.92</td><td align="center" colspan="2" rowspan="1">3.51&#x000b1;0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">LMCA disease</td><td align="center" colspan="2" rowspan="1">10 (27.77)</td><td align="center" colspan="2" rowspan="1">24 (18.46)</td><td align="center" colspan="2" rowspan="1">34 (20.48)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ACCT=aortic cross-clamp time; BMI=body mass index; DM=diabetes mellitus;
LMCA=left main coronary artery; PAD=peripheral arterial diseases;
TPT=total perfusion time</p></fn></table-wrap-foot></table-wrap><p>Logistic regression analysis revealed that the model was compatible and significant
according to risk factors (omnibus chi-square=24.052, <italic>P</italic>=0.013). In
addition, in the model, 11 variables explained 21% of CAS development in patients
who underwent CABG (Negelkerke R square=0.208). Older age (OR=1.064, 95%
CI%=1.015-1.116, <italic>P</italic>=0.011) and a history of CVA (OR=0.135, 95%
CI%=0.021-0.869, <italic>P</italic>=0.035) increased the risk of CAS development
(<xref rid="t2" ref-type="table">Table 2</xref>). There were no significant
differences in terms of gender (<italic>P</italic>=0.632), DM
(<italic>P</italic>=0.984), HT (<italic>P</italic>=0.274), dyslipidemia
(<italic>P</italic>=0.431), BMI (<italic>P</italic>=0.938), smoking
(<italic>P</italic>=0.585), history of PAD (<italic>P</italic>=0.595), number of
graft vessels (<italic>P</italic>=0.081), and LMCA disease
(<italic>P</italic>=0.433) (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Results of risk factors for significant carotid stenosis (&#x02265;50% luminal
narrowing).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Factors</th><th align="center" rowspan="1" colspan="1">B</th><th align="center" rowspan="1" colspan="1">SE</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">Odds ratio</th><th align="center" rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.062</td><td align="center" rowspan="1" colspan="1">0.024</td><td align="center" rowspan="1" colspan="1">0.011</td><td align="center" rowspan="1" colspan="1">1.064</td><td align="center" rowspan="1" colspan="1">1.015-1.116</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">-0.352</td><td align="center" rowspan="1" colspan="1">0.735</td><td align="center" rowspan="1" colspan="1">0.632</td><td align="center" rowspan="1" colspan="1">0.703</td><td align="center" rowspan="1" colspan="1">0.167-2.968</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">-0.009</td><td align="center" rowspan="1" colspan="1">0.438</td><td align="center" rowspan="1" colspan="1">0.984</td><td align="center" rowspan="1" colspan="1">0.991</td><td align="center" rowspan="1" colspan="1">0.420-2.339</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">-0.636</td><td align="center" rowspan="1" colspan="1">0.582</td><td align="center" rowspan="1" colspan="1">0.274</td><td align="center" rowspan="1" colspan="1">0.529</td><td align="center" rowspan="1" colspan="1">0.169-1.656</td></tr><tr><td align="left" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">-0.354</td><td align="center" rowspan="1" colspan="1">0.450</td><td align="center" rowspan="1" colspan="1">0.431</td><td align="center" rowspan="1" colspan="1">0.702</td><td align="center" rowspan="1" colspan="1">0.290-1.695</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">0.005</td><td align="center" rowspan="1" colspan="1">0.069</td><td align="center" rowspan="1" colspan="1">0.938</td><td align="center" rowspan="1" colspan="1">1.005</td><td align="center" rowspan="1" colspan="1">0.879-1.150</td></tr><tr><td align="left" rowspan="1" colspan="1">History of PAD</td><td align="center" rowspan="1" colspan="1">-0.356</td><td align="center" rowspan="1" colspan="1">0.671</td><td align="center" rowspan="1" colspan="1">0.595</td><td align="center" rowspan="1" colspan="1">0.700</td><td align="center" rowspan="1" colspan="1">0.188-2.608</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">0.369</td><td align="center" rowspan="1" colspan="1">0.674</td><td align="center" rowspan="1" colspan="1">0.585</td><td align="center" rowspan="1" colspan="1">1.446</td><td align="center" rowspan="1" colspan="1">0.386-5.423</td></tr><tr><td align="left" rowspan="1" colspan="1">History of CVA</td><td align="center" rowspan="1" colspan="1">-2.003</td><td align="center" rowspan="1" colspan="1">0.950</td><td align="center" rowspan="1" colspan="1">0.035</td><td align="center" rowspan="1" colspan="1">0.135</td><td align="center" rowspan="1" colspan="1">0.021-0.869</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of graft vessels</td><td align="center" rowspan="1" colspan="1">0.424</td><td align="center" rowspan="1" colspan="1">0.243</td><td align="center" rowspan="1" colspan="1">0.081</td><td align="center" rowspan="1" colspan="1">1.527</td><td align="center" rowspan="1" colspan="1">0.949-2.457</td></tr><tr><td align="left" rowspan="1" colspan="1">LMCA disease</td><td align="center" rowspan="1" colspan="1">-0.396</td><td align="center" rowspan="1" colspan="1">0.504</td><td align="center" rowspan="1" colspan="1">0.433</td><td align="center" rowspan="1" colspan="1">0.673</td><td align="center" rowspan="1" colspan="1">0.250-1.809</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>BMI=body mass index; CVA=cerebrovascular accident; DM=diabetes mellitus;
LMCA=left main coronary artery; PAD=peripheral arterial disease</p></fn></table-wrap-foot></table-wrap><p>The overall incidence of CVA after CABG was 1.20% (n=2). Postoperative CVA rate was
5.55% (n=2) in the stenosis group, and no CVAs were observed in the group without
stenosis. CAS increased the risk of postoperative CVA after CABG (omnibus
chi-square=6.203, <italic>P</italic>=0.013). None of the patients died from
complications due to postoperative CVA. Preoperative evaluation of the two patients
who developed CVA revealed that one patient had 60% stenosis in the left ICA and the
other had 30% stenosis in the left ICA and 60% stenosis in the right ICA. During the
early postoperative period, ipsilateral hemiplegia developed in one (0.60%) patient,
and this patient had a history of CVA 6 months ago. CVA (motor aphasia and
quadriplegia) developed on the 6<sup>th</sup> postoperative day in the other
patient. These patients with major CVA were discharged with neurological sequelae at
the 2<sup>nd</sup> and 3<sup>rd</sup> postoperative months after treatment at the
neurology clinic. In the follow-up program for CAS, 28 patients with moderate
stenosis in any of the carotid arteries and one patient with asymptomatic 70%
stenosis and no CEA were enrolled.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Cerebrovascular complication is the one of the most dreadful complications after
CABG, with a reported incidence of 2.1 to 5.2%, and results in acute mortality of up
to 38%<sup>[<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r13" ref-type="bibr">13</xref>]</sup>. In patients planned to undergo CABG, the rate of
severe CAS is 6% (range 3.2-8.7%)<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r16" ref-type="bibr">16</xref>]</sup>. In the present
study, the prevalence of severe CAS was 4.81% (n=8). Two of these eight patients had
total occlusion. Patients with heart problems that have been resolved but who have
had a CVA during the postoperative period remain mostly bedbound at the end of
prolonged hospitalization periods and are also frequently lost. In a comprehensive
study, the 30-day CVA risk after CABG was 1.1%<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. In their study on 1499 patients undergoing cardiac
surgery, Adams et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup> found
the rate of perioperative CVA of 1.73% (26 patients). Carotid disease is an
important etiological factor in the pathophysiology of CVA after CABG. However, even
assuming that prophylactic carotid endarterectomy carried no additional risk, it
could prevent only approximately 40 to 50% of procedural CVAs<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Although CVA after CABG is
multifactorial, CAS may be the cause of CVA through various mechanisms. Carotid
intraplaque hemorrhage can result in plaque destabilization and intimal ulceration,
creating a nidus for thromboembolism. Anticoagulating patients during CABG might be
responsible for the increased intraoperative risk of intraplaque hemorrhage.
Mechanical causes can also trigger intraplaque hemorrhage, such as turbulent blood
flow and hypertension, which can occur during cardiac surgery. Impaired cerebral
hemodynamic function distal to CAS is another determinant of CVA
post-CABG<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. In our
study, the prevalence of CVA after CABG was 1.20% (n=2) within 30 days. This can be
explained by the identification of patients with severe CAS in the preoperative
period and the performance of CEA.</p><p>The fact that patients who are planned for CABG and who have severe CAS are largely
asymptomatic during the preoperative period creates difficulties in the
diagnosis<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Therefore,
the comorbidity of coronary and carotid artery disease should be evaluated in detail
during the preoperative period. Khan et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup> reported that color Doppler sonography is nowadays the
first imaging examination performed for the diagnosis of carotid artery stenosis.
Its dual ability to evaluate both morphologic and hemodynamic abnormalities and its
cost-effectiveness make color Doppler ultrasound the only test applied before a
therapeutic decision<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>.</p><p>Some studies have examined the necessity of screening the carotid artery system of
patients with DUS during the preparation stage before CABG. Okur et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> recommended that coronary artery
patients aged &#x0003c;65 years old should also be routinely screened by DUS in the
preoperative evaluation, regardless of risk factors. Using preoperative carotid DUS,
Cornily et al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> found that the
rate of severe CAS was 5.8% (n=12) in 205 consecutive patients undergoing CABG. They
also identified severe CAS as a risk factor for postoperative CVA and recommended
selective screening with carotid DUS in patients aged &#x0003e;70 years old, with carotid
bruit, with a history of cerebrovascular disease, DM or PAD. In 2018, the European
Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS)
Guidelines recommended carotid DUS in patients aged &#x02265;70 years old with no
history of CVA/TIA in the last 6 months (class IIb, level of evidence B)<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. In our study, the mean age of
eight patients with &#x02265;70% stenosis was 66.00&#x000b1;11.94 (range 54-82) years,
and 50% (n=4) of these eight patients were &#x0003c;70 years old. If we had performed
selective carotid DUS in patients aged &#x02265;70 years old, these four patients
would not have been detected. In their study with 3708 patients who underwent open
heart surgery, Ascher et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>
found that the prevalence of significant carotid disease was &#x0003e;4.5% in patients
aged &#x0003e;60 years old. In that study, routine carotid DUS was recommended for
patients aged &#x0003e;60 years old, regardless of the accompanying risk factors, whereas
carotid DUS was recommended in patients aged &#x0003c;60 years old, when there were at
least two major risk factors such as hypertension, DM, and smoking.</p><p>In their study on 722 cardiac surgery patients, of whom 36.3% had coronary artery
disease, Chun et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>
identified independent risk factors for CAS as peripheral vascular disease after a
previous CVA and coronary artery disease with left main or three-vessel disease.
Anastasiadis et al.<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> found that a
history of CVA and the presence of bruit on clinical examination were significant
predictors of severe carotid disease. In our study, age and history of CVA were
identified as risk factors for CAS. PAD is strongly associated with CAS.
Preoperative screening with carotid DUS provides valuable information on
asymptomatic CAS and identifies patients with severe asymptomatic CAS who are at a
high risk of CVA to consider more intensive management of carotid disease in PAD
patients<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>. In our
study, 10.24% (n=17) patients had PAD, and PAD was not identified as a risk factor
for CAS. CAS rate is higher in patients with LMCA disease<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. In our study, 20.48% (n=34) of patients
undergoing CABG had LMCA disease, but LMCA disease was not a risk factor for
CAS.</p><p>Carotid angiography is a gold standard method for the diagnosis of carotid artery
disease. However, carotid DUS is more frequently used because it is non-invasive and
easily applicable in clinical practice. Taneja et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup> recommend the incorporation of this commonly
available and easy-to-use bedside technique of Doppler examination of the carotid
vessels in routine intraoperative practice as the standard of care in all patients
undergoing CABG<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. In our
clinic, carotid DUS screening is performed routinely regardless of risk factors in
all patients undergoing CABG. Carotid artery system angiography is performed in
patients with &#x02265;70% stenosis detected by DUS, and treatment options are
determined according to the symptomatic condition of the patient. We consider it
important to identify patients with moderate CAS during the post-CABG period and to
enroll these patients in follow-up programs. In our study, 16.86% (n=28) of 166 CABG
patients with carotid DUS had moderate stenosis in either carotid artery. With the
addition of one patient who did not undergo CEA, a total of 29 patients were
enrolled in the follow-up program for CAS.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Routine carotid DUS method aims to reduce the risk of postoperative CVA caused by
severe CAS in patients undergoing CABG. At the same time, indirect CVA risks, such
as determining the location of central venous catheterization and necessity of not
reducing the pump pressure, are also reduced by identifying CAS in patients, even
when it is not at the surgical margin. In addition, identifying and monitoring
patients with moderate CAS during the postoperative period will help reduce the risk
of late CVA in these patients.</p><p>In conclusion, this study demonstrated that age and a history of CVA are independent
risk factors for CAS in CABG patients. We recommend carotid screening for all
patients undergoing CABG patients, regardless of the absence of associated risk
factors.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">HK</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; final approval of
the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Cardiovascular Surgery, Giresun
Ada Hospital, Giresun, Turkey.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dacey</surname><given-names>LJ</given-names></name><name><surname>Likosky</surname><given-names>DS</given-names></name><name><surname>Leavitt</surname><given-names>BJ</given-names></name><name><surname>Lahey</surname><given-names>SJ</given-names></name><name><surname>Quinn</surname><given-names>RD</given-names></name><name><surname>Hernandez</surname><given-names>F Jr</given-names></name><etal/></person-group><article-title>Perioperative stroke and long-term survival after coronary bypass
graft surgery</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><issue>2</issue><fpage>532</fpage><lpage>536</lpage><comment>discussion 537</comment><pub-id pub-id-type="doi">10.1016/j.athoracsur.2004.07.027</pub-id><pub-id pub-id-type="pmid">15680829</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastasiadis</surname><given-names>K</given-names></name><name><surname>Karamitsos</surname><given-names>TD</given-names></name><name><surname>Velissaris</surname><given-names>I</given-names></name><name><surname>Makrygiannakis</surname><given-names>K</given-names></name><name><surname>Kiskinis</surname><given-names>D</given-names></name></person-group><article-title>Preoperative screening and management of carotid artery disease
in patients undergoing cardiac surgery</article-title><source>Perfusion</source><year>2009</year><volume>24</volume><issue>4</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1177/0267659109347404</pub-id><pub-id pub-id-type="pmid">19755466</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharmasaroja</surname><given-names>PA</given-names></name><name><surname>Uransilp</surname><given-names>N</given-names></name><name><surname>Watcharakorn</surname><given-names>A</given-names></name><name><surname>Piyabhan</surname><given-names>P</given-names></name></person-group><article-title>Accuracy of carotid duplex criteria in diagnosis of significant
carotid stenosis in asian patients</article-title><source>J Stroke Cerebrovasc Dis</source><year>2018</year><volume>27</volume><issue>3</issue><fpage>778</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2017.10.014</pub-id><pub-id pub-id-type="pmid">29153302</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okur</surname><given-names>FF</given-names></name><name><surname>Akpinar</surname><given-names>MB</given-names></name><name><surname>Uyar</surname><given-names>IS</given-names></name><name><surname>Abacilar</surname><given-names>AF</given-names></name><name><surname>Yurtman</surname><given-names>V</given-names></name><name><surname>Sahin</surname><given-names>V</given-names></name><etal/></person-group><article-title>Age groups as a risk factor in isolated coronary and concomitant
carotid artery surgery</article-title><source>Turk J Vasc Surg</source><year>2011</year><volume>20</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><comment>Turkish</comment></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>North american symptomatic carotid endarterectomy trial
collaborators</collab><name><surname>Barnett</surname><given-names>HJM</given-names></name><name><surname>Taylor</surname><given-names>DW</given-names></name><name><surname>Haynes</surname><given-names>RB</given-names></name><name><surname>Sackett</surname><given-names>DL</given-names></name><name><surname>Peerless</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Beneficial effect of carotid endarterectomy in symptomatic
patients with high-grade stenosis</article-title><source>N Engl J Med</source><year>1991</year><volume>325</volume><issue>7</issue><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1056/NEJM199108153250701</pub-id><pub-id pub-id-type="pmid">1852179</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>European carotid surgery triallists collaborative group</collab></person-group><article-title>Randomised trial of endarterectomy for recently symptomatic
carotid stenosis: final results of the MRC European carotid surgery trial
(ECST)</article-title><source>Lancet</source><year>1998</year><volume>351</volume><issue>9113</issue><fpage>1379</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)09292-1</pub-id><pub-id pub-id-type="pmid">9593407</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The asymptomatic carotid atherosclerosis study group</collab></person-group><article-title>Study design for randomized prospective trial of carotid
endarterectomy for asymptomatic atherosclerosis</article-title><source>Stroke</source><year>1989</year><volume>20</volume><issue>7</issue><fpage>844</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1161/01.str.20.7.844</pub-id><pub-id pub-id-type="pmid">2665205</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Bown</surname><given-names>MJ</given-names></name></person-group><article-title>Stroke after cardiac surgery and its association with
asymptomatic carotid disease: an updated systematic review and
meta-analysis</article-title><source>Eur J Vasc Endovasc Surg</source><year>2011</year><volume>41</volume><issue>5</issue><fpage>607</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2011.02.016</pub-id><pub-id pub-id-type="pmid">21396854</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>EG</given-names></name><name><surname>Benson</surname><given-names>CB</given-names></name><name><surname>Moneta</surname><given-names>GL</given-names></name><name><surname>Alexandrov</surname><given-names>AV</given-names></name><name><surname>Baker</surname><given-names>JD</given-names></name><name><surname>Bluth</surname><given-names>EI</given-names></name><etal/></person-group><article-title>Carotid artery stenosis: gray-scale and doppler US
diagnosis&#x000ac;--society of radiologists in ultrasound cosensus
conference</article-title><source>Radiology</source><year>2003</year><volume>229</volume><issue>2</issue><fpage>340</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1148/radiol.2292030516</pub-id><pub-id pub-id-type="pmid">14500855</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauv&#x000e9;</surname><given-names>JS</given-names></name><name><surname>Thorpe</surname><given-names>KE</given-names></name><name><surname>Sackett</surname><given-names>DL</given-names></name><name><surname>Taylor</surname><given-names>W</given-names></name><name><surname>Barnett</surname><given-names>HJ</given-names></name><name><surname>Haynes</surname><given-names>RB</given-names></name><etal/></person-group><article-title>Can bruits distinguish high-grade from moderate symptomatic
carotid stenosis? The North American symptomatic carotid endarterectomy
trial</article-title><source>Ann Intern Med</source><year>1994</year><volume>120</volume><issue>8</issue><fpage>633</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-120-8-199404150-00002</pub-id><pub-id pub-id-type="pmid">8135446</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarakji</surname><given-names>KG</given-names></name><name><surname>Sabik 3rd</surname><given-names>JF</given-names></name><name><surname>Bhudia</surname><given-names>SK</given-names></name><name><surname>Batizy</surname><given-names>LH</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Temporal onset, risk factors, and outcomes associated with stroke
after coronary artery bypass grafting</article-title><source>JAMA</source><year>2011</year><volume>305</volume><issue>4</issue><fpage>381</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.37</pub-id><pub-id pub-id-type="pmid">21266685</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>DJ</given-names></name><name><surname>Perler</surname><given-names>BA</given-names></name><name><surname>Roseborough</surname><given-names>GS</given-names></name><name><surname>Grega</surname><given-names>MA</given-names></name><name><surname>Borowicz</surname><given-names>LM Jr</given-names></name><name><surname>Baumgartner</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Mandatory versus selective preoperative carotid screening: a
retrospective analysis</article-title><source>Ann Thorac Surg</source><year>2004</year><volume>78</volume><issue>1</issue><fpage>159</fpage><lpage>166</lpage><comment>discussion 159-66</comment><pub-id pub-id-type="doi">10.1016/j.athoracsur.2004.02.024</pub-id><pub-id pub-id-type="pmid">15223422</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar</surname><given-names>JD</given-names></name><name><surname>Witky</surname><given-names>RJ</given-names></name><name><surname>Grega</surname><given-names>MA</given-names></name><name><surname>Borowicz</surname><given-names>LM</given-names></name><name><surname>Doty</surname><given-names>JR</given-names></name><name><surname>Petrofski</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Stroke after cardiac surgery: short-and long-term
outcomes</article-title><source>Ann Thorac Surg</source><year>2001</year><volume>72</volume><issue>4</issue><fpage>1195</fpage><lpage>1201</lpage><comment>discussion 1201-2</comment><pub-id pub-id-type="doi">10.1016/s0003-4975(01)02929-0</pub-id><pub-id pub-id-type="pmid">11603436</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faggioli</surname><given-names>GL</given-names></name><name><surname>Curl</surname><given-names>GR</given-names></name><name><surname>Ricotta</surname><given-names>JJ</given-names></name></person-group><article-title>The role of carotid screening before coronary artery
bypass</article-title><source>J Vasc Surg</source><year>1990</year><volume>12</volume><issue>6</issue><fpage>724</fpage><lpage>729</lpage><comment>discussion 729-31</comment><pub-id pub-id-type="doi">10.1067/mva.1990.24458</pub-id><pub-id pub-id-type="pmid">2243408</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masabni</surname><given-names>K</given-names></name><name><surname>Raza</surname><given-names>S</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Gornik</surname><given-names>HL</given-names></name><name><surname>Sabik 3rd</surname><given-names>JF</given-names></name></person-group><article-title>Does preoperative carotid stenosis screening reduce perioperative
stroke in patients undergoing coronary artery bypass
grafting?</article-title><source>J Thorac Cardiovasc Surg</source><year>2015</year><volume>149</volume><issue>5</issue><fpage>1253</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2015.02.003</pub-id><pub-id pub-id-type="pmid">25816954</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatachalam</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>BH</given-names></name><name><surname>Mukherjee</surname><given-names>D</given-names></name><name><surname>Shishehbor</surname><given-names>MH</given-names></name></person-group><article-title>Contemporary management of concomitant carotid and coronary
artery disease</article-title><source>Heart</source><year>2011</year><volume>97</volume><issue>3</issue><fpage>175</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1136/hrt.2010.203612</pub-id><pub-id pub-id-type="pmid">21156674</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Milojevic</surname><given-names>M</given-names></name><name><surname>Daemen</surname><given-names>J</given-names></name><name><surname>Ahn</surname><given-names>JM</given-names></name><name><surname>Boersma</surname><given-names>E</given-names></name><name><surname>Christiansen</surname><given-names>EH</given-names></name><etal/></person-group><article-title>Stroke rates following surgical versus percutaneous coronary
revascularization</article-title><source>J Am Coll Cardiol</source><year>2018</year><comment>24</comment><volume>72</volume><issue>4</issue><fpage>386</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2018.04.071</pub-id><pub-id pub-id-type="pmid">30025574</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>BC</given-names></name><name><surname>Clark</surname><given-names>RM</given-names></name><name><surname>Paap</surname><given-names>C</given-names></name><name><surname>Goff</surname><given-names>JM Jr</given-names></name></person-group><article-title>There is no benefit to universal carotid artery duplex screening
before a major cardiac surgical procedure</article-title><source>Ann Vasc Surg</source><year>2014</year><volume>28</volume><issue>1</issue><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2013.06.018</pub-id><pub-id pub-id-type="pmid">24220649</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Mehta</surname><given-names>Z</given-names></name><name><surname>Rothwell</surname><given-names>PM</given-names></name><name><surname>Bell</surname><given-names>PR</given-names></name></person-group><article-title>Carotid artery disease and stroke during coronary artery bypass:
a critical review of the literature</article-title><source>Eur J Vasc Endovasc Surg</source><year>2002</year><volume>23</volume><issue>4</issue><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1053/ejvs.2002.1609</pub-id><pub-id pub-id-type="pmid">11991687</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snider</surname><given-names>F</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Manni</surname><given-names>R</given-names></name><name><surname>Modugno</surname><given-names>P</given-names></name><name><surname>Glieca</surname><given-names>F</given-names></name><name><surname>Scapigliati</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combined surgery for cardiac and carotid disease: management and
results of a rational approach</article-title><source>Eur J Vasc Endovasc Surg</source><year>2000</year><volume>20</volume><issue>6</issue><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1053/ejvs.2000.1237</pub-id><pub-id pub-id-type="pmid">11136587</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Lashari</surname><given-names>NA</given-names></name><name><surname>Lakho</surname><given-names>NI</given-names></name><name><surname>Faisal</surname><given-names>A</given-names></name><name><surname>Hussain</surname><given-names>A</given-names></name></person-group><article-title>Cerebral ischaemia and stroke; role of carotid
doppler</article-title><source>Professional Med J</source><year>2017</year><volume>24</volume><issue>12</issue><fpage>1823</fpage><lpage>1827</lpage><pub-id pub-id-type="doi">10.17957/TPMJ/17.4001</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornily</surname><given-names>JC</given-names></name><name><surname>Le Saux</surname><given-names>D</given-names></name><name><surname>Vinsonneau</surname><given-names>U</given-names></name><name><surname>Bezon</surname><given-names>E</given-names></name><name><surname>Le Ven</surname><given-names>F</given-names></name><name><surname>Le Gal</surname><given-names>G</given-names></name><etal/></person-group><article-title>Assessment of carotid artery stenosis before coronary artery
bypass surgery: Is it always necessary?</article-title><source>Arch Cardiovasc Dis</source><year>2011</year><volume>104</volume><issue>2</issue><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.acvd.2010.11.008</pub-id><pub-id pub-id-type="pmid">21402341</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>FJ</given-names></name><name><surname>Sousa-Uva</surname><given-names>M</given-names></name><name><surname>Ahlsson</surname><given-names>A</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Banning</surname><given-names>AP</given-names></name><name><surname>Benedetto</surname><given-names>U</given-names></name><etal/></person-group><article-title>2018 ESC/EACTS guidelines on myocardial
revascularization</article-title><source>Eur Heart J</source><year>2019</year><volume>40</volume><issue>2</issue><fpage>87</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy394</pub-id><pub-id pub-id-type="pmid">30165437</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascher</surname><given-names>E</given-names></name><name><surname>Hingorani</surname><given-names>A</given-names></name><name><surname>Yorkovich</surname><given-names>W</given-names></name><name><surname>Ramsey</surname><given-names>PJ</given-names></name><name><surname>Salles-Cunha</surname><given-names>S</given-names></name></person-group><article-title>Routine preoperative carotid duplex scanning in patients
undergoing open heart surgery: is it worthwhile?</article-title><source>Ann Vasc Surg</source><year>2001</year><volume>15</volume><issue>6</issue><fpage>669</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1007/s10016-001-0088-6</pub-id><pub-id pub-id-type="pmid">11769149</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>LH</given-names></name><name><surname>Tsai</surname><given-names>J</given-names></name><name><surname>Tam</surname><given-names>M</given-names></name><name><surname>Prema</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>LH</given-names></name><name><surname>Patel</surname><given-names>KK</given-names></name></person-group><article-title>Screening carotid artery duplex in patients undergoing cardiac
surgery</article-title><source>Ann Vasc Surg</source><year>2014</year><volume>28</volume><issue>5</issue><fpage>1178</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2013.07.025</pub-id><pub-id pub-id-type="pmid">24211602</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Park</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>DI</given-names></name><name><surname>Nam</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Association between carotid artery stenosis and peripheral artery
disease: evaluation by screening carotid ultrasonography (cross-sectional
study)</article-title><source>Medicine (Baltimore)</source><year>2019</year><volume>98</volume><issue>6</issue><elocation-id>e14163</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000014163</pub-id><pub-id pub-id-type="pmid">30732131</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Agostino</surname><given-names>RS</given-names></name><name><surname>Svensson</surname><given-names>LG</given-names></name><name><surname>Neumann</surname><given-names>DJ</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><name><surname>Williamson</surname><given-names>WA</given-names></name><name><surname>Shahian</surname><given-names>DM</given-names></name></person-group><article-title>Screening carotid ultrasonography and risk factors for stroke in
coronary artery surgery patients</article-title><source>Ann Thorac Surg</source><year>1996</year><volume>62</volume><issue>6</issue><fpage>1714</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(96)00885-5</pub-id><pub-id pub-id-type="pmid">8957376</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taneja</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Kapoor</surname><given-names>PM</given-names></name><name><surname>Jagia</surname><given-names>P</given-names></name><name><surname>Bisoi</surname><given-names>AK</given-names></name></person-group><article-title>Prevalence of carotid artery stenosis in neurologically
asymptomatic patients undergoing coronary artery bypass grafting for
coronary artery disease: role of anesthesiologist in preoperative assessment
and intraoperative management</article-title><source>Ann Card Anaesth</source><year>2016</year><volume>19</volume><issue>1</issue><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.4103/0971-9784.173024</pub-id><pub-id pub-id-type="pmid">26750678</pub-id></element-citation></ref></ref-list></back></article>